Product Details for: Rybrevant

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
350MG/7ML (50MG/ML)
Single-Dose Vial
351(a)
Rybrevant
Rx
Proper Name
amivantamab-vmjw
BLA Number
761210
Applicant
Janssen Biotech, Inc.
Original Approval Date
May 21, 2021
Date of First Licensure
RETURN TO SEARCH RESULTS